Article
Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes.
JNCI cancer spectrum - 1 Feb 2021
Kurian Allison W, Ward Kevin C, Abrahamse Paul, Hamilton Ann S, Katz Steven J
Abstract excerpt
Breast cancer patients increasingly undergo genetic testing. To examine chemotherapy indications for germline pathogenic variant (PV) carriers, we linked results of germline testing to Georgia and California Surveillance, Epidemiology, and End Results registry records, including 21-gene recurrence score (RS) results, for breast cancer patients diagnosed in 2013-2017. All statistical tests were 2-sided. Patients...
Topics
- Adult
- Age Factors
- Aged
- Ataxia Telangiectasia Mutated Proteins
- Breast Neoplasms
- California
- Checkpoint Kinase 2
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Fanconi Anemia Complementation Group N Protein
- Female
